Women who are carriers of mutated BRCA genes are known to have a significantly higher risk for developing breast and ovarian cancers than those who don't have the mutations. But a new study by the University of California Los Angeles (UCLA) faculty questions the value of screening for the genetic mutations in the general population — including those who do not have cancer or have no family history of the disease — because of the high cost.

Despite numerous major changes looming in the healthcare industry, the 2015 edition of the Great American Physician Survey found that U.S. physicians are still happy in their careers.

School-age children born prematurely are more likely to have low mathematical achievement, thought to be associated with reduced working memory and number skills, according to a study in the neurology journal Brain.

Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business Innovation Research (SBIR) grant up to $1.8 million from the National Cancer Institute (NCI), National Institutes of Health (NIH). The grant will be used to fund preclinical studies examining the safety of intravenous (IV) injection of Tc99m tilmanocept, a Manocept platform product.

Eizo Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis on its 5-megapixel monochrome medical monitor, the RadiForce GX540.

Mobius Medical Systems recently released DoseLab version 6.7. This new release adds significant features to the quality assurance (QA) software, including task scheduling and monitoring, role-based control and enhanced Microsoft Excel integration.

CMS, Medicare Advantage, Value-Based Insurance Design model, VBID, chronic conditions

The Centers for Medicare & Medicaid Services (CMS) announced the creation of the Medicare Advantage Value-Based Insurance Design Model, designed to improve care and reduce costs in Medicare Advantage plans.

Results of the PLATFORM trial indicate fractional flow reserve computed tomography (FFR-CT) can obviate the need for invasive tests in up to 61 percent of patients with chest pain and suspected coronary artery disease. The results were presented at the European Society of Cardiology (ESC) Congress 2015.

Linköping University Hospital in Sweden has installed SyMRI Neuro from SyntheticMR in order to improve the follow-up of patients with multiple sclerosis (MS).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now